The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam
| Status: | Archived |
|---|---|
| Conditions: | Osteoporosis, Postmenopausal Syndrome |
| Therapuetic Areas: | Endocrinology, Rheumatology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | November 2010 |
| End Date: | July 2011 |
The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam, a Cytochrome P450 3A4/P-gp (CYP3A4) Substrate, in Postmenopausal Osteoporotic Women
This is a multi-center, open-label, drug-drug interaction study in postmenopausal women with
osteoporosis.
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials